{"nct_id":"NCT03469349","title":"Actovegin 12-Week Treatment Given First Intravenously and Subsequently Orally in Participants With Peripheral Arterial Occlusive Disease Fontaine Stage IIB","status":"COMPLETED","status_verified_date":"2020-10","start_date":"2018-05-01","start_date_type":"ACTUAL","primary_completion_date":"2019-05-28","primary_completion_date_type":"ACTUAL","completion_date":"2019-08-28","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["TAK"]}